For the Inventor, By the Inventor

Enter assignee name

Maple Grove, MN, United States of America

Upsher Smith Laboratories, Inc.

USPTO Granted Patents = 31

% Expired Patents = 29.0

CIPO Patents = 2

Trademarks = 38

Forward Citations = 167

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Victoria Ann O'Neill (7 out of 19 patents)

Sarah Michelle Betterman (6 out of 6 patents)

Laura Marie Patrick (6 out of 6 patents)

4. Jaidev Srinivas Tantry (5 out of 5 patents)

5. Kenneth L Evenstad (5 out of 8 patents)

6. James S Jensen (4 out of 4 patents)

7. Stephen M Berge (4 out of 7 patents)

8. Christian F Wertz (4 out of 8 patents)

9. Harish K Pimplaskar (3 out of 3 patents)

10. Gloria A Rood (3 out of 3 patents)

11. Prabhu Prabhakara (2 out of 4 patents)

12. Rajesh Ramesh Patil (2 out of 4 patents)

13. Piyush Gupta (2 out of 4 patents)

14. Rajeev Singh Raghuvanshi (2 out of 22 patents)

15. Anil N Namboodiripad (2 out of 6 patents)

Core Competencies:

Pharmaceutical Composition

Migraine Treatment

Triptan Compounds

Extended-Release Capsules

Testosterone Gel

Dermatological Compositions

Non-Opioid Amine

Anti-Inflammatory Drug

Opioid-Containing Compositions

Granules

Vitamin Supplement

Benign Prostate Hyperplasia

31 patents: Sort by Forward Citations

1. 11364224 - Pharmaceutical composition for treating migraine (2022-06-21),

2. 11337962 - Formulations comprising triptan compounds (2022-05-24),

3. 10603305 - Formulations comprising triptan compounds (2020-03-31),

4. 10537554 - Pharmaceutical composition for treating migraine (2020-01-21),

5. 10363224 - Extended-release topiramate capsules (2019-07-30),

6. 10172878 - Extended-release topiramate capsules (2019-01-08),

7. 9662340 - Testosterone gel compositions and related methods (2017-05-30),

8. 9555005 - Extended-release topiramate capsules (2017-01-31),

9. 9456985 - Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug (2016-10-04),

10. 9456970 - Dermatological compositions and methods (2016-10-04),

11. 9295675 - Testosterone gel compositions and related methods (2016-03-29),

12. 9101545 - Extended-release topiramate capsules (2015-08-11),

13. 9023390 - Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug (2015-05-05),

14. 8987291 - Opioid-containing oral pharmaceutical compositions and methods (2015-03-24),

15. 8889190 - Extended-release topiramate capsules (2014-11-18),

Company Overview

Upsher Smith Laboratories, Inc. is a pharmaceutical company based in Maple Grove, Minnesota, specializing in the development and manufacturing of generic and branded prescription medications. The company focuses on therapeutic areas such as neurology, dermatology, and women's health, aiming to provide innovative solutions that enhance patient care. With a commitment to quality and compliance, Upsher Smith leverages advanced technologies and research to deliver effective pharmaceutical products to healthcare providers and patients across the United States.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

31 Patents

#11 in Maple Grove, MN

#311 in Minnesota

#10,936 in US

#21,284 in the World

Maple Grove, MN, United States of America

Upsher Smith Laboratories, Inc.

Forward Citations = 167

29 inventors:

Victoria Ann O'Neill (7 out of 19 patents)

Sarah Michelle Betterman (6 out of 6 patents)

Laura Marie Patrick (6 out of 6 patents)

4. Jaidev Srinivas Tantry (5 out of 5 patents)

5. Kenneth L Evenstad (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Upsher Smith Laboratories, Inc.. Retrieved from https://idiyas.com/company/upsher-smith-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…